Lucentix Company

Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva by using a low-cost handheld device giving laboratory-quality results. The company's biosensors are based on the invention of a new type of biochemical sensing molecule. A light-producing enzyme calledluciferase, is engineered to change the color of the emitted light in response to changes in analyte concentration. In absence of the analyte the molecular system emits red light, while at high analyte concentration the light is blue.
Technology: Health Monitoring
Industry: Deep Diagnostics
Headquarters: Vaud
Founded Date: 01.01.2015
Funding Status: Seed
Investors Number: 1
Last Funding Type: Seed

Visit Website
Register and Claim Ownership